An emerging startup focused on bringing artificial intelligence-powered robotics to the cardiac catheterization laboratory has successfully raised $160 million in a new funding round. The investment was backed by major industry players, including GE HealthCare, alongside other participating investors. This substantial capital injection highlights growing interest and financial support for integrating advanced AI and robotics technologies into medical procedures within cath labs. Further details regarding the startup's specific product roadmap, leadership team, or deployment timelines were not disclosed in the announcement.